CENPL and invasive breast carcinoma: The data of Figures 4C–F suggested that patients that had breast invasive carcinoma with CENPL mutation had worse prognosis in DFS (p = 0.0334), DSS (p = 3.717e-3), and PFS (p = 7.430e-3), but not OS (p = 0.0693).